Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 22997460)

1.

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Chan AT, Grégoire V, Lefebvre JL, Licitra L, Hui EP, Leung SF, Felip E; EHNS–ESMO–ESTRO Guidelines Working Group.

Ann Oncol. 2012 Oct;23 Suppl 7:vii83-5. No abstract available.

2.

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Chan AT, Grégoire V, Lefebvre JL, Licitra L, Felip E; EHNS-ESMO-ESTRO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v187-9. doi: 10.1093/annonc/mdq186. No abstract available.

3.

Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

ESMO Guidelines Working Group, Chan AT, Hui EP, Leung SF.

Ann Oncol. 2007 Apr;18 Suppl 2:ii67-8. No abstract available. Erratum in: Ann Oncol. 2008 May;19(5):1027-9.

4.

Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Chan AT, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2008 May;19 Suppl 2:ii81-2. doi: 10.1093/annonc/mdn098. No abstract available.

5.

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Cardoso F, Fallowfield L, Costa A, Castiglione M, Senkus E; ESMO Guidelines Working Group.

Ann Oncol. 2011 Sep;22 Suppl 6:vi25-30. doi: 10.1093/annonc/mdr372. No abstract available.

6.

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E; ESMO Guidelines Working Group.

Ann Oncol. 2012 Oct;23 Suppl 7:vii11-9. No abstract available.

7.

[Advance in diagnosis and management of local recurrent nasopharyngeal carcinoma].

Lu TX.

Ai Zheng. 2004 Feb;23(2):230-4. Review. Chinese.

PMID:
14960253
8.

The role of MRI for the diagnosis of recurrence of nasopharyngeal cancer.

Fujii M, Kanzaki J.

Auris Nasus Larynx. 1994;21(1):32-7.

PMID:
7980192
9.

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Pacini F, Castagna MG, Brilli L, Pentheroudakis G; ESMO Guidelines Working Group.

Ann Oncol. 2012 Oct;23 Suppl 7:vii110-9. No abstract available.

10.

Nasopharyngeal carcinoma.

Chong VF, Ong CK.

Eur J Radiol. 2008 Jun;66(3):437-47. doi: 10.1016/j.ejrad.2008.03.029. Epub 2008 May 15. Review.

PMID:
18485650
11.

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Grégoire V, Lefebvre JL, Licitra L, Felip E; EHNS-ESMO-ESTRO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v184-6. doi: 10.1093/annonc/mdq185. No abstract available.

12.

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Cardoso F, Senkus-Konefka E, Fallowfield L, Costa A, Castiglione M; ESMO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v15-9. doi: 10.1093/annonc/mdq160. No abstract available.

13.

[Clinical characteristics and salvage treatment for recurrent nasopharyngeal carcinoma].

Han F, Lu TX.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Mar;47(3):261-4. Chinese. No abstract available.

PMID:
22805037
14.

Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Kataja V, Castiglione M; ESMO Guidelines Working Group.

Ann Oncol. 2008 May;19 Suppl 2:ii11-3. doi: 10.1093/annonc/mdn072. No abstract available.

15.

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi33-8. doi: 10.1093/annonc/mdt353. No abstract available.

16.

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Dreyling M, Ghielmini M, Marcus R, Salles G, Vitolo U, Ladetto M; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii76-82. doi: 10.1093/annonc/mdu200. Epub 2014 Aug 13. No abstract available.

PMID:
25122695
17.

Nasopharyngeal cancer: epidemiology, staging, and treatment.

Fandi A, Altun M, Azli N, Armand JP, Cvitkovic E.

Semin Oncol. 1994 Jun;21(3):382-97. Review. No abstract available.

PMID:
8209270
18.

SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013.

Mesía R, Pastor M, Grau JJ, del Barco E; SEOM.

Clin Transl Oncol. 2013 Dec;15(12):1025-9. doi: 10.1007/s12094-013-1094-1. Epub 2013 Aug 27.

PMID:
23982852
19.

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Dreyling M, Geisler C, Hermine O, Kluin-Nelemans HC, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii83-92. doi: 10.1093/annonc/mdu264. No abstract available.

PMID:
25210087
20.

[Adenoid cystic carcinoma (cylindroma) of the nasopharynx with extension into the cavernous sinus].

Aloulou S, Merad-Boudia Z.

Presse Med. 2002 Oct 26;31(35):1653-6. French.

PMID:
12448331
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk